The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announce a publication in Emerging Microbes & Infections, a peer-reviewed medical journal, sharing the results of a study on intranasally delivered Sputnik V coronavirus vaccine. The study shows this type of the vaccine induces a strong and durable […]
A unique independent nationwide observational study in EU member state Hungary estimating and directly comparing efficacy of five vaccines against COVID has demonstrated that the Russian Sputnik V vaccine has the highest (98%) efficacy in preventing COVID-related mortality and 85.7% efficacy against coronavirus infection leading alongside the vaccine by Moderna. The study based on the […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the real-world data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine demonstrating it is 80% effective against coronavirus infection from 6th to 8th months after administering the second dose. Efficacy of Sputnik V on 6-8 […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the Russian Sputnik V coronavirus vaccine has demonstrated 96.3% efficacy and high safety profile based on new study of vaccinated individuals in the Republic of Belarus. An article analyzing efficacy of Sputnik V vaccine against coronavirus during vaccination campaign in Belarus has been published […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces a new publication by the Gamaleya Center in The Lancet, one of the world’s most respected medical journals, showing the one-shot Sputnik Light vaccine against coronavirus demonstrates a high safety profile and induces a strong humoral and cellular immune response. RDIF has sponsored the […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the results of a comprehensive real world study by the Ministry of Health of the City of Buenos Aires (Argentina) confirming high efficacy of the Russian Sputnik V vaccine in protecting individuals aged at least 60 years. The study has been published by The […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Israeli authorities have granted approval for entry of individuals vaccinated with the Sputnik V vaccine. To date, a total of 101 countries have approved entry of those to have received the Sputnik V vaccine. Key requirements of the 101 countries which allow visits […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Gamaleya National Research Center of Epidemiology and Microbiology today announced the results of an efficacy analysis of the one-shot Sputnik Light vaccine against infection from the Delta variant of coronavirus. Gamaleya Center has submitted an article analyzing efficacy of Sputnik Light vaccine against the […]
All obstacles preventing the certification of the Russian Sputnik V vaccine against coronavirus by the World Health Organization (WHO) have been removed, Russian Health Minister Mikhail Murashko said at a briefing in Geneva. “All barriers have been lifted as of today. We do not see any obstacles for continuing our work. This was confirmed by […]
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health of the Islamic Republic of Iran. Sputnik Light vaccine is based on human adenovirus serotype 26 which is the first component of the Sputnik V vaccine. Immunization […]
